Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05367128
Other study ID # YM111015F
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 25, 2022
Est. completion date June 2023

Study information

Verified date September 2022
Source National Yang Ming University
Contact Ray-Yau Wang, PhD
Phone +886-2-2826-7210
Email rywang@nycu.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this single-blinded three-armed randomized controlled trial is to investigate the effect of different task prioritization during dual task training on dual task performance.


Description:

Introduction: Many activities of daily livings involve performing two tasks simultaneously, i.e. dual tasking. Performing dual task increases the demand on attentional resources, which may further decrease the dual task performance, especially in older adults. According to capacity sharing theory, the two tasks compete and influence with each other due to limited attention and information processing capacity. It has been noted that task prioritization during dual tasking may influence the dual task performance. Previous study indicated that supraposture-focus strategy resulted in better posture and task performance in older people. On the other hand, it is known that dual task training improved dual task performance. However, the effects of applying task prioritization during dual task training have not yet been investigated. Therefore, the purpose of this study is to investigate the effect of different task prioritization during dual task training on dual task performance. Methods: Participants will be randomized into three groups: posture-focus, supraposture-focus and control group. Participants will receive a total of 12 sessions of cognitive dual task training with different prioritization strategies, i.e. prioritization on posture, cognitive or neither task. Walking and task performance during dual task walking, executive function, and balance performance will be assessed before and after the interventions (pre- and post-test).


Recruitment information / eligibility

Status Recruiting
Enrollment 39
Est. completion date June 2023
Est. primary completion date June 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Age = 65 years old - MMSE scores > 24 Exclusion Criteria: - Unstable health conditions - Any neurological, psychological disease or diagnosis of learning disability which interferes the participation in this study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Dual task training
All participants will receive cognitive dual task training for 30 min/session, 2-3 sessions/week for 4-6 weeks (a total of 12 sessions). The cognitive dual task training includes 15 min of cognitive task combining with standing task and 15 min of cognitive task combining with walking task. The differences among group are the instructions of task prioritization given by the therapist

Locations

Country Name City State
Taiwan National Yang Ming Chiao Tung University Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Yang Ming University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dual task walking performance assessment- speed (m/s) Using GaitUp system to evaluate gait speed during cognitive and motor dual task walking Change from baseline dual task walking speed and up to 6 weeks (pre- and post-test)
Primary Dual task walking performance assessment- cadence (steps/min) Using GaitUp system to evaluate cadence during cognitive and motor dual task walking Change from baseline dual task walking cadence and up to 6 weeks (pre- and post-test)
Primary Dual task walking performance assessment- stride length variability (CV, %) Using GaitUp system to evaluate stride length variability during cognitive and motor dual task walking Change from baseline dual task walking stride length variability and up to 6 weeks (pre- and post-test)
Primary Dual task walking performance assessment- stride time variability (CV, %) Using GaitUp system to evaluate stride time variability during cognitive and motor dual task walking Change from baseline dual task walking stride time variability and up to 6 weeks (pre- and post-test)
Primary Rate of dual task cost- gait speed (%) Using the dual and single task walking speed to calculate the dual task cost of gait speed Change from baseline dual task cost and up to 6 weeks (pre- and post-test)
Secondary Trail Making Test Use Trail Making Test (TMT)-Chinese version to indicate executive function. The duration for completing the test will be measured, and the shorter duration means the better executive function. Change from baseline Trail Making Test and up to 6 weeks (pre- and post-test)
Secondary Berg Balance Scale Use Berg Balance Scale (BBS) to assess balance performance. Berg balance scale scoring ranges from 0 to 56. The higher scores indicate better balance performance. Change from baseline Berg Balance Scale and up to 6 weeks (pre- and post-test)
Secondary Single task walking performance assessment- speed (m/s) Using GaitUp system to evaluate gait speed during single walking Change from baseline single task walking speed and up to 6 weeks (pre- and post-test)
Secondary Single task walking performance assessment- cadence (steps/min) Using GaitUp system to evaluate cadence during single walking Change from baseline single task walking cadence and up to 6 weeks (pre- and post-test)
Secondary Single task walking performance assessment- stride length variability (CV, %) Using GaitUp system to evaluate stride length variability during single walking Change from baseline single task walking stride length variability and up to 6 weeks (pre- and post-test)
Secondary Single task walking performance assessment- stride time variability (CV, %) Using GaitUp system to evaluate stride time variability during single walking Change from baseline dual task walking stride time variability and up to 6 weeks (pre- and post-test)
Secondary Cognitive dual task walking performance assessment- correct number (times) The number of the correct answer for serially subtracting "7" from a predefined 3-digit number during cognitive dual task walking task will be recorded. Change from baseline cognitive dual task walking performance and up to 6 weeks (pre- and post-test)
Secondary Motor dual task walking performance assessment- number of go (pieces) The number of successfully transferred go pieces from one side to another during motor dual task walking task will be recorded. Change from baseline motor dual task walking performance and up to 6 weeks (pre- and post-test)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1